Confirmed efficacy and safety of dual therapy based in lamivudine plus a ritonavir-boosted protease inhibitor in the clinical setting

被引：0
|
作者：
Fontecha-Ortega, Maria [1 ]
Munoz-Mendoza, Vanessa [2 ]
Gomez, Cristina [3 ]
Sanchez-Conde, Matilde [3 ]
Angel Rodriguez, Miguel [3 ]
Jesus Vivancos, Maria [3 ]
Luis Casado, Jose [3 ]
机构：
[1] Hosp Getafe, Internal Med, Getafe, Spain
[2] Hosp Obispo Polanco, Internal Med, Teruel, Spain
[3] Hosp Ramon & Cajal, Infect Dis, Madrid, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P103
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression
    Hung, Tung-Che
    Chen, Guan-Jhou
    Cheng, Shu-Hsing
    Chen, Jhen-Hong
    Wei, Jheng-Lun
    Cheng, Chien-Yu
    Hung, Chien-Ching
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (06) : 865 - 871
  • [2] Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy
    Lichterfeld, M
    Wöhrmann, A
    Schmeisser, N
    Fätkenheuer, G
    Salzberger, B
    Wyen, C
    Schmitz, K
    Sauerbruch, T
    Rockstroh, JK
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2003, 8 (02) : 56 - 60
  • [3] Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study
    Blanco, Jose L.
    Rojas, Jhon
    de Lazzari, Elisa
    Inciarte, Alexy
    Subirana, Mar
    Callau, Pilar
    Martinez-Rebollar, Maria
    Laguno, Montserrat
    Mallolas, Josep
    de la Mora, Lorena
    Torres, Berta
    Gonzalez-Cordon, Ana
    Martinez, Esteban
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (07) : 1974 - 1979
  • [4] Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy
    Brayer, Samuel W.
    Reddy, K. Rajender
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) : 547 - 558
  • [5] Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials
    Hill, A.
    Moyle, G.
    HIV MEDICINE, 2007, 8 (04) : 259 - 264
  • [6] Effectiveness of monotherapy with a ritonavir-boosted protease inhibitor for HIV patients in clinical practice
    Moron Romero, Rocio
    Valle, Margarita
    Rodriguez, Alejandro
    Nieto, Pelayo
    Casas, Inmaculada
    Cabeza, Jose
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 330 - 330
  • [7] Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group
    Curran, Adrian
    Monteiro, Polyana
    Domingo, Pere
    Villar, Judit
    Imaz, Arkaitz
    Martinez, Esteban
    Fernandez, Irene
    Knobel, Hernando
    Podzamczer, Daniel
    Antonio Iribarren, Jose
    Penaranda, Maria
    Crespo, Manuel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1390 - 1396
  • [8] Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice
    Gantner, Pierre
    Bani-Sadr, Firouze
    Garraffo, Rodolphe
    Roger, Pierre-Marie
    Treger, Michele
    Jovelin, Thomas
    Pugliese, Pascal
    Rey, David
    PLOS ONE, 2016, 11 (10):
  • [9] Efficacy and Safety of an NRTI-Sparing Dual Regimen of Raltegravir and Ritonavir-Boosted Protease Inhibitor in a Triple Antiretroviral Class-Experienced Population
    Allavena, C.
    Mounoury, O.
    Rodallec, A.
    Reliquet, V.
    Billaud, E.
    Raffi, F.
    HIV CLINICAL TRIALS, 2009, 10 (05): : 337 - 340
  • [10] Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
    Lopez-Cortes, Luis F.
    Castano, Manuel A.
    Lopez-Ruz, Miguel A.
    Rios-Villegas, Maria J.
    Hernandez-Quero, Jose
    Merino, Dolores
    Jimenez-Aguilar, Patricia
    Marquez-Solero, Manuel
    Terron-Pernia, Alberto
    Tellez-Perez, Francisco
    Viciana, Pompeyo
    Orihuela-Canadas, Francisco
    Palacios-Baena, Zaira
    Vinuesa-Garcia, David
    Fajardo-Pico, Jose M.
    Romero-Palacios, Alberto
    Ojeda-Burgos, Guillermo
    Pasquau-Liano, Juan
    PLOS ONE, 2016, 11 (02):
12345